Home
About
Overview
Sharing Data
ORCID
Help
History (10)
A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary Fibrosis.
Pulse Wave Velocity in Chronic Obstructive Pulmonary Disease and the Impact of Inhaled Therapy (SUMMIT): A Randomized Double-Blind Clinical Trial.
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.
Development of the chronic obstructive pulmonary disease morning symptom diary (COPD-MSD).
Precision medicine in COPD: where are we and where do we need to go?
See All 10 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Precision medicine in COPD: where are we and where do we need to go?
Sidhaye VK, Nishida K, Martinez FJ. Precision medicine in COPD: where are we and where do we need to go? Eur Respir Rev. 2018 Sep 30; 27(149).
View in:
PubMed
subject areas
Clinical Decision-Making
Early Diagnosis
Genetic Markers
Genetic Predisposition to Disease
Humans
Lung
Phenotype
Precision Medicine
Predictive Value of Tests
Pulmonary Disease, Chronic Obstructive
Treatment Outcome
authors with profiles
Fernando J Martinez MD, MS